Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ironwood Pharmaceuti (IRWD)

Ironwood Pharmaceuti (IRWD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,386,546
  • Shares Outstanding, K 156,495
  • Annual Sales, $ 346,640 K
  • Annual Income, $ -282,370 K
  • 60-Month Beta 1.68
  • Price/Sales 4.05
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.10
  • Number of Estimates 6
  • High Estimate 0.15
  • Low Estimate 0.03
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +126.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.69 +0.12%
on 08/23/19
11.97 -27.32%
on 07/31/19
-2.22 (-20.33%)
since 07/23/19
3-Month
8.69 +0.12%
on 08/23/19
12.37 -29.67%
on 06/19/19
-2.38 (-21.48%)
since 05/23/19
52-Week
8.69 +0.12%
on 08/23/19
19.64 -55.70%
on 08/31/18
-9.68 (-52.67%)
since 08/23/18

Most Recent Stories

More News
Shares of IRWD Down 30.5% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Ironwood Pharmac (NASDAQ:IRWD) on March 28th, 2019 at $12.77. In approximately 5 months, Ironwood Pharmac has returned 30.54% as of today's recent price of $8.87.

IRWD : 8.72 (-1.58%)
Ironwood Pharmac Set to Possibly Rebound After Yesterday's Selloff of 1.34%

Ironwood Pharmac (NASDAQ:IRWD) traded in a range yesterday that spanned from a low of $8.76 to a high of $8.89. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $8.77...

IRWD : 8.72 (-1.58%)
Ironwood Pharmac Set to Possibly Rebound After Yesterday's Selloff of 1.23%

Ironwood Pharmac (NASDAQ:IRWD) traded in a range yesterday that spanned from a low of $8.86 to a high of $9.10. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $8.93...

IRWD : 8.72 (-1.58%)
Ironwood Pharmaceuticals Announces Full Exercise of Convertible Notes Over-Allotment

Ironwood Pharmaceuticals, Inc. ("Ironwood") (Nasdaq: IRWD), a GI-focused healthcare company, today announced that, in connection with its previously announced offering of 0.75% Convertible Senior Notes...

IRWD : 8.72 (-1.58%)
Ironwood Pharmaceuticals and Alnylam Pharmaceuticals Enter U.S. GI Disease Education and Promotional Agreement for Alnylam's Givosiran in Acute Hepatic Porphyria (AHP)

--- Alnylam to leverage Ironwood's leading capabilities in GI to help raise AHP awareness and bring givosiran (if approved) to gastroenterologists and other healthcare practitioners in the U.S. -

IRWD : 8.72 (-1.58%)
ALNY : 81.89 (-0.33%)
Alnylam Pharmaceuticals and Ironwood Pharmaceuticals Enter U.S. GI Disease Education and Promotional Agreement for Alnylam's Givosiran in Acute Hepatic Porphyria (AHP)

--- Alnylam to leverage Ironwood's leading capabilities in GI to help raise AHP awareness and bring givosiran (if approved) to gastroenterologists and other healthcare practitioners in the U.S. -

IRWD : 8.72 (-1.58%)
ALNY : 81.89 (-0.33%)
After Yesterday's Decline of 1.15%, Ironwood Pharmac Offers Investors Better Value

Ironwood Pharmac (NASDAQ:IRWD) traded in a range yesterday that spanned from a low of $9.32 to a high of $9.59. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $9.46...

IRWD : 8.72 (-1.58%)
Ironwood Pharmaceuticals Announces Pricing of Upsized $350 Million Convertible Senior Notes Offering

Ironwood Pharmaceuticals, Inc. ("Ironwood") (Nasdaq: IRWD), a GI-focused healthcare company, today announced the pricing of $175 million aggregate principal amount of convertible senior unsecured notes...

IRWD : 8.72 (-1.58%)
Ironwood Pharmaceuticals Announced Proposed Offering of $330 Million of Convertible Senior Notes

Ironwood Pharmaceuticals, Inc. ("Ironwood") (Nasdaq: IRWD), a GI-focused healthcare company, today announced that it intends to offer, subject to market and other conditions, $165 million aggregate principal...

IRWD : 8.72 (-1.58%)
Ironwood Pharmac Shares Down 21.7% Since SmarTrend's Sell Call (IRWD)

SmarTrend identified a Downtrend for Ironwood Pharmac (NASDAQ:IRWD) on March 28th, 2019 at $12.77. In approximately 4 months, Ironwood Pharmac has returned 21.69% as of today's recent price of $10.00....

IRWD : 8.72 (-1.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade IRWD with:

Business Summary

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome...

See More

Key Turning Points

2nd Resistance Point 9.14
1st Resistance Point 9.00
Last Price 8.72
1st Support Level 8.73
2nd Support Level 8.61

See More

52-Week High 19.64
Fibonacci 61.8% 15.46
Fibonacci 50% 14.16
Fibonacci 38.2% 12.87
Last Price 8.72
52-Week Low 8.69

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar